| INTRODUCTION
Titanium (Ti) is a lustrous transition metal that is widely used as an implant material in medicine and dentistry, and, in its oxide form, as a white pigment in personal care products and food. It is often chosen as an implant material, owing to its corrosion resistance and good biocompatibility. 1, 2 Many new Ti implant applications are being developed, and, because the age of the western population is increasing, human exposure to Ti is also increasing. 3, 4 Although Ti is generally believed to be "hypo-allergenic", numerous articles have been published describing allergic reactions to Ti. [5] [6] [7] The prevalence of Ti allergy is not known, but is estimated to be very low. Reports on Ti allergy have been summarized by Wood et al and Fage et al. 8, 9 They describe adverse effects of Ti, namely, local and systemic symptoms such as local eczema in areas over an implant, pruritus, pain, chronic fatigue syndrome, and neurological symptoms.
Clinical experience with dental and orthopaedic implant patients suggests that Ti allergy occurs more often than patch tests indicate. [10] [11] [12] The most widely used patch test preparation is Ti dioxide (TiO 2 ), but it rarely confirms clinical suspicion. This might be explained by its poor solubility, resulting in inadequate skin penetration. 6, 7 Other Ti salts, such as Ti(IV) chloride, Ti(II) sulfate, Ti(IV) diethanedioate, Ti salicylate, Ti(IV) tetrahydroxide, calcium titanate, Ti(III) nitride, and Ti(IV) oxalate hydrate, have been suggested, but only a few studies have actually examined the use of these salts. 9, 13 In our clinic, during the past 10 years, different Ti test salts have been applied to evaluate possible sensitization to Ti. In this study, our objective was to report the frequency of positive patch test reactions to Ti dioxide and its alternatives applied in our clinic. In addition, this article describes the clinical presentation of Ti-allergic patients in our clinic. assessed. An allergen was considered to be clinically relevant if:
| MATERIALS AND METHODS
(1) the existence of exposure could be established, and (2) the patient's complaints could be explained (completely or partially) with regard to that exposure. The relevance was categorized as complete, partial, past, no and unknown relevance. 15 Evaluations were performed by an experienced dermatologist.
A 2-tailed Fisher's exact test was used, as appropriate, to compare proportions of positive reactions to the Ti compounds in patients suspected of having Ti allergy with those in patients in the control group.
The significance level for all analyses was P < .05.
| RESULTS
A total of 458 patients were tested with ≥1 Ti salts (see Table S1 for combinations and numbers). At least 1 positive result was noted in Tables 4 and 5 .
| DISCUSSION
We performed a retrospective study on all patients patch tested with Ti salts in our hospital. A key finding is that the frequency of Ti sensitivity in this large group of patients was 5.7%. This frequency was higher than the sensitivity found in a study by Sicilia et al, which was 0.6%, and that found in a study by Lhotka et al, which was 2%. 7, 16 However, in these studies, only TiO 2 was used, which might account for the difference in sensitization occurrence from that in our study. A study in Lithuania reported no positive patch test reaction to any of the 5 Ti salts present in their metal series. 17 However, only a relatively small number of patients were tested. There are currently no reports in which a panel of Ti salts has been used on a large patch test population.
We tested a highly selected population; therefore, the high frequency of Ti sensitization that we found cannot be extrapolated to the general population. In the group of patients suspected of having Ti allergy, an even higher frequency of 8.9% was observed. Interestingly, this frequency was not statistically different from the frequency found in the control group (P = .39). This may be explained by the small sample size of the control group and the relatively low numbers of positive reactions within both groups. Also, the possible referral bias resulting from the selection of patients on the basis of their clinical history has to be taken into account. The potential differences in accuracy of the Ti salts should also be considered. The retrospective nature of this study makes it difficult to address these problems. This is similar to our experience, in which 8 patients who reacted positively to Ti oxalate were also tested with TiO 2 ; none of the tests gave a positive result. However, the difference in frequency of positive Ti oxalate reactions between patients suspected of having Ti allergy and the control group was non-significant (P = .74). As outlined above, this lack of significance may be attributable to unequal group sizes (n = 174 vs n = 38) and the retrospective nature of this study. This made statistical analysis for comparison of the groups difficult.
Nevertheless, positive reactions in the control group, in which sensitization to Ti is highly unlikely, highlight the possibility of falsepositive reactions. This is emphasized by the fact that 13 of the 17 positive subjects were tested with 2 Ti oxalate hydrate patches, but no concomitant reaction was seen in 8 (61.5%) of these subjects.
Ti oxalate may be irritant in nature, owing to the low pH of 2.0-3.0 reactions makes it an interesting patch test salt for further investigation. This is emphasized by Basketter et al, who described 3 TiO 2 -negative patients who had positive reactions to a complex Ti lactate. 25 Investigating Ti isopropoxide could also be interesting, as it gave positive reactions in 8 patients. However, these results are enigmatic: patients, suggesting Ti allergy. 10 In contrast, Park et al, 26 using a local lymph node assay, found that TiO 2 was not a dermal sensitizer.
In both the literature and this study, Ti allergy typically occurred in implant patients suffering from postoperative complaints. We identified erythema, dermatitis (overlying the implant or elsewhere), and local swelling. Patients also reported pruritus, a burning sensation, and pain. These results are in line with those of previous studies. However, the relationship between implant-related complaints and allergy remains much debated. Determining the relevance of a positive test reaction in these patients is a challenge. Although we describe relevance in 61.5%, it was difficult to determine whether a positive reaction was putatively responsible for the clinical complaints. Given the multifactorial background of the above-mentioned complaints, other factors, such as aseptic loosening, osteolysis and infection, may also play a significant role. 27 Moreover, possible sensitization to other components within the implant makes it complex to determine whether Ti is the primary cause, is an aggravating factor, or is not involved at all in the pathogenesis of the clinical complaints. It was sometimes difficult, and often impossible, to retrospectively determine the relative influences of all these different factors; hence the high amount of partial relevance in our study. Sufficient information on previous diagnostic outcomes and implanted materials is therefore crucial. Fortunately, the composition of dental implants and reconstructive materials can be determined by taking microsamples. 28 This method also detects possible trace metals that are not listed by the manufacturer or registered by the clinician, but may be involved in the clinical manifestation. In addition, a study by Bernard et al showed the presence of many impurities in commercialized Ti patch test samples. 23 Even though there is no proof that the level of impurities in the patch test Ti salts is sufficient to cause elicitation, it highlights the importance of testing all implanted materials and investigating the existence of allergenic exposures.
Our study had several limitations. It was a retrospective study, so it was difficult to assign relevance, designate a control group, and rule out the possibility of referral bias occurring. In addition, not all of the patients were screened with the same salts, as the Ti series has expanded over the last 10 years. However, our study is the first to test a panel of Ti salts on a large patch test population. Future prospective studies could avoid these limitations, and further assess the accuracy of Ti patch test salts.
In conclusion, the frequency of Ti sensitivity in our patch test 
